BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29331996)

  • 1. Relevance of enlarged cardiophrenic lymph nodes in determining prognosis of patients with advanced ovarian cancer.
    Nuruzzaman HSM; Tan GHC; Nadarajah R; Teo M
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29331996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
    Cowan RA; Tseng J; Murthy V; Srivastava R; Long Roche KC; Zivanovic O; Gardner GJ; Chi DS; Park BJ; Sonoda Y
    Gynecol Oncol; 2017 Nov; 147(2):262-266. PubMed ID: 28888540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
    Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
    Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer.
    Luger AK; Steinkohl F; Aigner F; Jaschke W; Marth C; Zeimet AG; Reimer D
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1092-1099. PubMed ID: 32112653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the implications of radiologically abnormal cardiophrenic lymph nodes in advanced ovarian cancer? An analysis of tumour burden, surgical complexity, same-site recurrence and overall survival.
    Addley S; Asher V; Kirke R; Bali A; Abdul S; Phillips A
    Eur J Surg Oncol; 2022 Dec; 48(12):2531-2538. PubMed ID: 35718677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Status of Metastatic Cardiophrenic Lymph Nodes (CPLNs) in Patients With Ovarian Cancer: A Review.
    Acs M; Piso P; Prader S
    Anticancer Res; 2022 Jan; 42(1):13-24. PubMed ID: 34969704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
    Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiophrenic lymph node resection in advanced ovarian cancer: surgical outcomes, pre- and postoperative imaging.
    Salehi S; Mohammar R; Suzuki C; Joneborg U; Hjerpe E; Torbrand C; Falconer H
    Acta Oncol; 2018 Jun; 57(6):820-824. PubMed ID: 29182048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy.
    Eoh KJ; Yoon JW; Lee I; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
    J Surg Oncol; 2017 Sep; 116(3):329-336. PubMed ID: 28542980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence.
    Jamieson A; Sykes P; Eva L; Bergzoll C; Simcock B
    Gynecol Oncol; 2017 Aug; 146(2):273-278. PubMed ID: 28549816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer.
    Prader S; Harter P; Grimm C; Traut A; Waltering KU; Alesina PF; Heikaus S; Ataseven B; Heitz F; Schneider S; du Bois A
    Gynecol Oncol; 2016 May; 141(2):271-275. PubMed ID: 26972337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography.
    Kim TH; Lim MC; Kim SI; Seo SS; Kim SH; Park SY
    Ann Surg Oncol; 2016 Apr; 23(4):1302-8. PubMed ID: 26714941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Cardiophrenic Lymph Node Status After Neoadjuvant Chemotherapy in Primary Advanced Ovarian Cancer.
    Luengas-Wuerzinger V; Rawert F; CLAßEN-VON Spee S; Baransi S; Schuler E; Carrizo K; Mallmann P; Lampe B
    Anticancer Res; 2021 Oct; 41(10):5025-5031. PubMed ID: 34593451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdiaphragmatic cardiophrenic lymph node resection for Stage IV ovarian cancer.
    LaFargue CJ; Bristow RE
    Gynecol Oncol; 2015 Sep; 138(3):762-3. PubMed ID: 26049122
    [No Abstract]   [Full Text] [Related]  

  • 15. Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer.
    Prader S; Vollmar N; du Bois A; Heitz F; Schneider S; Ataseven B; Bommert M; Waltering KU; Heikaus S; Koch JA; Alesina PF; Traut A; Harter P
    Gynecol Oncol; 2019 Jan; 152(1):76-81. PubMed ID: 30463683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative Ultrasound-Guided Excision of Cardiophrenic Lymph Nodes in an Advanced Ovarian Cancer Patient.
    Moro F; Uccella S; Testa AC; Scambia G; Fagotti A
    Int J Gynecol Cancer; 2018 Nov; 28(9):1672-1675. PubMed ID: 30371564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD.
    Chekerov R; Braicu I; Castillo-Tong DC; Richter R; Cadron I; Mahner S; Woelber L; Marth C; Van Gorp T; Speiser P; Zeillinger R; Vergote I; Sehouli J
    Int J Gynecol Cancer; 2013 Feb; 23(2):268-75. PubMed ID: 23358178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study.
    Spiliotis J; Halkia E; Lianos E; Kalantzi N; Grivas A; Efstathiou E; Giassas S
    Ann Surg Oncol; 2015 May; 22(5):1570-5. PubMed ID: 25391263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of Transabdominal Cardiophrenic Lymphnode Dissection in Advanced Ovarian Cancer: Initial Experience at a Tertiary Center.
    Garbi A; Zanagnolo V; Colombo N; Aletti G; Achilarre MT; Bocciolone L; Landoni F; Rizzo S; Biffi R; Maggioni A
    Int J Gynecol Cancer; 2017 Jul; 27(6):1268-1273. PubMed ID: 28498236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of CT detected enlarged cardiophrenic nodes in ovarian cancer patients.
    Oommen I; Chandramohan A; Raji PS; Thomas A; Joel A; Samuel Ram T; Peedicayil A
    Abdom Radiol (NY); 2021 Jan; 46(1):331-340. PubMed ID: 32577780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.